This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

8 Stocks Soaring on High Volume

Theravance

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Theravance (THRX - Get Report) is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. This stock is trading up 3.9% at $29.45 in recent trading.

Today's Volume: 694,000

Average Volume: 491,792

Volume % Change: 62%

Shares of THRX are moving smartly to the upside today after Piper Jaffray raised its price target on the stock due to its positive LAMA/LABA Phase III data and maintains its overweight rating on the shares.

>>5 Health Care Stocks Setting Up to Break Out

From a technical perspective, THRX is showing some follow-through momentum buying here with high volume. This stock has been in a monster uptrend for the last month and change, with shares rally from a low of $17.06 to today's high of $29.87. During that move, shares of THRX have been making higher lows and higher highs, which is bullish technical price action. This move today has also pushed THRX into major breakout territory, since the stock has moved above some past overhead resistance at $28.95.

Traders should now look for long-biased trades as long as THRX is trending above $28.95 to $28.25 with strong upside volume flows. I would consider any upside volume day that registers near or above 491,792 shares as bullish. If we continue to see that action, then THRX could hit $32 to $35 in the near future.

Keep in mind, though, that this stock is getting overbought since its relative strength index reading is now 81.49. Only look for long trades if THRX can hold the breakout and today's low.

As of the most recently reported quarter, Theravance was one of Seth Klarman's Baupost Group holdings.

6 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
BWLD $155.48 0.00%
HCSG $30.21 0.00%
NFLX $621.87 0.00%
QLIK $37.24 0.00%
THRX $16.65 0.00%

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs